新生儿高胆红素血症的全球视角
本文综述新生儿黄疸的流行病学全球负担,包括患病率估计及致命与非致命健康结局,并讨论严重高胆红素血症的管理与核黄疸预防。严重高胆红素血症及后遗症在工业化国家仍存在,中低收入国家负担尤其高,主要因有效治疗延迟。
要点
- 黄疸是新生儿常见良性表现,但也是生后第一周住院的主要原因之一。
- 严重高胆红素血症可进展为急性胆红素脑病和核黄疸,有新生儿死亡和长期神经发育损害风险。
- 中低收入国家负担尤其高,主要因高效治疗延迟。
核心结论
- 严重高胆红素血症及其后遗症在具备医疗体系的工业化国家仍发生,中低收入国家负担尤其高。
研究设计与样本
- 本文为综述,总结新生儿黄疸流行病学最新证据,基于患病率估计及致命与非致命健康结局的全球负担。
主要发现
- 黄疸在新生儿中普遍且常为良性,但是生后第一周住院的主要原因之一。
- 部分婴儿黄疸可加重,进展为急性胆红素脑病和核黄疸,有新生儿死亡和长期神经发育损害风险。
- 中低收入国家严重高胆红素血症负担尤其高,主要因高效治疗延迟。
临床怎么用
- 综述讨论严重高胆红素血症的管理,包括核黄疸的预防,并指出未来研究方向。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hyperbilirubinaemia, presenting as jaundice, is a ubiquitous and frequently benign condition in newborn babies but is a leading cause of hospitalisation in the first week of life. In some infants jaundice can become severe, progressing to acute bilirubin encephalopathy and kernicterus with a substantial risk of neonatal mortality and long-term neurodevelopmental impairments. Severe hyperbilirubinaemia and its sequelae continue to occur in industrialised countries with functioning medical systems and a disproportionately high burden also persists in low-income and middle-income countries due primarily to delays in delivering effective treatments that are routinely available in high-income countries. In this Review we summarise up-to-date evidence on the epidemiology of neonatal jaundice including its global burden based on estimates of its prevalence, and both fatal and non-fatal health outcomes. We also discuss the management of severe hyperbilirubinaemia including the prevention of kernicterus, and highlight future directions for research.
引用
- Olusanya BO, Kaplan M, Hansen TWR, et al. Neonatal hyperbilirubinaemia: a global perspective. Lancet Child Adolesc Health. 2018. PMID: 30119720. doi:10.1016/S2352-4642(18)30139-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。